UPDATE : Monday, September 7, 2020
상단여백
Patients with ‘Invossa stigma’ struggle to get treatment, insurance
“I received Invossa injection in January, but the pain got worse. I’m getti...
by Jeong Sae-im  |  2019-06-26 13:22
라인
Oscotech wins exception policy for continued R&D for new drugs
The stock market regulator granted Oscotech to become the third KOSDAQ-list...
by Jeong Sae-im  |  2019-06-25 14:11
라인
‘Customized strategies needed for fast-changing Chinese drug regulation’
Foreign drugmakers need to make the most of China’s revised drug regulation...
by Jeong Sae-im  |  2019-06-21 14:12
라인
Despite regulator’s ruling delay, Kolon TissueGene likely to be reviewed for delisting
The stock market regulator said it has pushed back the deadline to decide w...
by Jeong Sae-im  |  2019-06-20 14:20
라인
‘Yuhan’s Lazertinib promising as 1st-line therapy for NSCLC’
Expectations are rising for Lazertinib, an investigational drug that Yuhan ...
by Jeong Sae-im  |  2019-06-18 14:43
라인
Korea can benchmark Philadelphia’s rise as ‘Cellicon Valley’: experts
Anticipation for the Korean biohealth industry is growing amid multinationa...
by Jeong Sae-im  |  2019-06-18 13:42
라인
Korean biosimilars take on original drugs in Europe
Korean biosimilars are threatening original drugs with improved competitive...
by Jeong Sae-im  |  2019-06-17 15:26
라인
294 shareholders file suit against Kolon TissueGene for damage compensation
Kolon TissueGene said in a public filing on Thursday that its 294 minority ...
by Jeong Sae-im  |  2019-06-14 10:51
라인
‘Many drugs won Chinese approval without review suspension’
Korean botulinum toxin maker Medytox is likely to face a delay in winning C...
by Jeong Sae-im  |  2019-06-13 11:26
라인
Daewoong’s botulinum toxin hits a snag in European approval
Daewoong Pharmaceutical is expected to face a delay in obtaining European a...
by Jeong Sae-im  |  2019-06-12 16:50
라인
‘Medytox got review suspension in China only once’
Korean botulinum toxin maker Medytox said the Chinese regulator ordered the...
by Jeong Sae-im  |  2019-06-11 10:50
라인
CJ HealthCare to invest ￦100 billion in new IV fluid factory
CJ HealthCare, a subsidiary of Kolmar Korea, said Monday it would invest 10...
by Jeong Sae-im  |  2019-06-10 16:17
라인
Medytox’ botulinum toxin may face approval delay in China
Korean botulinum toxin maker Medytox may likely suffer a delay in Chinese r...
by Jeong Sae-im  |  2019-06-10 13:55
라인
Kolon TissueGene CEO resigns
Kolon TissueGene, a subsidiary of Kolon Life Science, said Co-CEO Lee Woo-s...
by Jeong Sae-im  |  2019-06-07 15:35
라인
Pharma industry urges deregulation to develop new drug using AI
The Korean pharmaceutical industry called for the government to ease regula...
by Jeong Sae-im  |  2019-06-05 11:53
라인
FDA OKs phase-1 trial for Yuhan’s investigational lung cancer drug
Yuhan Corp. is gearing up to develop a new lung cancer drug Lazertinib (YH2...
by Jeong Sae-im  |  2019-06-04 14:21
라인
Kolon’s minority shareholders demand over ￦25 billion in damage
Minority shareholders of Kolon Life Science and its subsidiary Kolon Tissue...
by Jeong Sae-im  |  2019-06-03 14:53
라인
Invossa inventor sold Kolon shares at highest value
Former Kolon TissueGene CEO Lee Kwan-hee, the inventor of now-suspended gen...
by Jeong Sae-im  |  2019-06-03 14:52
라인
Hanmi’s hypertension drug was effective in phase-4 study 
Hanmi Pharmaceutical’s new combination drug Amosartan (losartan/amlodipine)...
by Jeong Sae-im  |  2019-05-31 16:05
라인
Until when will Kolon keep lying about Invossa?
Kolon Life Science’s “explanations” about the mislabeling of the cell ingre...
by Jeong Sae-im  |  2019-05-31 14:59
-이전1112-
176 civic groups furious over government-doctors deal176 civic groups furious over government-doctors deal
여백
Most viewed
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top